Powder -20°C 3 years; 4°C 2 years In solvent -80°C 6 months; -20°C 1 month
Research Area:
Cancer
Target:
HDAC
Description:
J22352 is a PROTAC (proteolysis-targeting chimeras)-like and highly selective HDAC6 inhibitor with an IC50 value of 4.7 nM. J22352 promotes HDAC6 degradation and induces anticancer effects.